Pharmaceutical company promotion: striking a balance
نویسندگان
چکیده
منابع مشابه
Striking a Balance
In recent years there has been an increased interest in investigating how technology can be used to aid the millions of people living in low-income countries [2]. Mobile phones are emerging as powerful, affordable and pervasive computing devices that can serve the needs of widely deployed applications in resource-constrained environments. Previous work has emphasized the importance of working c...
متن کاملPharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
Background Competing claims are made about the amount of money that pharmaceutical companies spend on research and development (R&D) versus promotion. This study investigates this question in the Canadian context. Methods Two methods for determining industry-wide figures for spending on promotion were employed. First, total industry spending on detailing and journal advertising for 2013-2016 ...
متن کاملStriking a balance with Recon 2.1
Recon 2 is a highly curated reconstruction of the human metabolic network. Whilst the network is state of the art, it has shortcomings, including the presence of unbalanced reactions involving generic metabolites. By replacing these generic molecules with each of their specific instances, we can ensure full elemental balancing, in turn allowing constraintbased analyses to be performed. The resu...
متن کاملFiltration in antarctic ascidians – striking a balance *
Retention efficiencies and pumping rates of the four Antarctic ascidian species Ascidia challengeri, Cnemidocarpa verrucosa, Corella eumyota and Molgula pedunculata from Potter Cove, King George Island, were measured. None of the species reached a 100% retention efficiency at any given particle size. Pumping rates of the four species range between 250 and 349 ml /h per gram of ash free dry mass...
متن کاملPharmaceutical Company Sponsorship of Research: A Review
Many studies have shown that pharmaceutical companies' funding of clinical trials is associated with pro-industry results. This article reviews the literature on that association, confirming its existence, and discusses its causes and potential responses. The mechanisms of industry influence are varied, more than is usually acknowledged. It is straightforward to identify a number of distinct ki...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian and New Zealand Journal of Medicine
سال: 1998
ISSN: 0004-8291
DOI: 10.1111/j.1445-5994.1998.tb01950.x